VANCOUVER, British Columbia--(BUSINESS WIRE)--By 2030, nearly 22 million new cancer cases are expected, and the burden on the healthcare system to quickly and accurately analyze the tissue samples to ...

Dec 10, 2021 – Nasdaq (Nasdaq: NDAQ) announces that trading in Aiforia Technologies Plc shares (short name: AIFORIA) commence today on Nasdaq First North Growth Market Finland. The company belongs to ...

The regional health management of Castile and León in Spain has selected Aiforia Technologies Plc as a partner for AI-assisted diagnostics. The contract is part of a tender with an initiative to ...

Aiforia Technologies Plc, a provider of cutting-edge AI-assisted medical software solutions, announced today that it has successfully obtained the In Vitro Diagnostic Regulation (IVDR) certification.

Dr. Leena Strauss has taught disease model pathology for the past decade. She is based at the University of Turku’s Institute of Biomedicine as a lecturer and researcher. Leena is one of the first ...

PORTSMOUTH, N.H., June 21, 2021 /PRNewswire/ -- Epredia, a global leader in precision cancer diagnostics, and Aiforia, a medical software company providing Artificial Intelligence (AI) based solutions ...

BOSTON, Oct. 14, 2020 /PRNewswire/ -- Aiforia, a leading provider of deep learning artificial intelligence (AI) solutions for image analysis across a variety of medical domains, has been granted U.S.

NeuroScience Associates (NSA Labs) and Aiforia are bringing together their respective expertise in neuroscience and artificial intelligence (AI). BOSTON, Feb. 24, 2020 – Aiforia Technologies, an ...

Aiforia Technologies Oyj engages in developing artificial intelligence-based image analysis software for medical research and diagnostics and aiming for international growth. It offers scalable ...